Novo Nordisk To Boost Output Capability
Wall Street Journal
Novo Nordisk said it plans to invest $2.3 billion to expand a pharmaceutical ingredient production facility in Denmark for its future portfolio within serious chronic diseases.
Understanding current events through the lenses of the past and future.
Wall Street Journal
Novo Nordisk said it plans to invest $2.3 billion to expand a pharmaceutical ingredient production facility in Denmark for its future portfolio within serious chronic diseases.